Literature DB >> 14944967

Effect of adrenocorticotropic hormone (ACTH) and cortisone administration in patients with myasthenia gravis and report of onset of myasthenia gravis during prolonged cortisone administration.

D GROB, A M HARVEY.   

Abstract

Entities:  

Keywords:  ACTH/therapeutic use; CORTISONE/toxicity; MYASTHENIA GRAVIS

Mesh：

Substances：

Year:  1952        PMID： 14944967

Source DB:  PubMed          Journal:  Bull Johns Hopkins Hosp        ISSN： 0097-1383


× No keyword cloud information.
  8 in total

Review 1.  [ACTH AND CORTICOID TREATMENT OF NEUROLOGIC DISEASES].

Authors:  H BAMMER
Journal:  Dtsch Z Nervenheilkd       Date:  1963-07-10

2.  [Clinical aspects of myopathy].

Authors:  H BECKER
Journal:  Dtsch Z Nervenheilkd       Date:  1955

3.  Benefit from adrenocorticotrophin in myasthenia gravis.

Authors:  L A Liversedge; G M Yuill; I M Wilkinson; J A Hughes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1974-04       Impact factor: 10.154

Review 4.  [The pathogenesis of myasthenia gravis as an immunological problem].

Authors:  J R Kalden
Journal:  Klin Wochenschr       Date:  1970-01-01

Review 5.  Immunopathology of acetylcholine receptors in myasthenia gravis.

Authors:  M E Seybold; J M Lindstrom
Journal:  Springer Semin Immunopathol       Date:  1982

6.  Controversies about the treatment of myasthenia gravis.

Authors:  L P Rowland
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-07       Impact factor: 10.154

Review 7.  Exacerbation of myasthenia gravis following corticosteroid treatment: what is the evidence? A systematic review.

Authors:  Itay Lotan; Mark A Hellmann; Adi Wilf-Yarkoni; Israel Steiner
Journal:  J Neurol       Date:  2020-10-16       Impact factor: 6.682

8.  Treatment of myasthenia gravis with adrenocorticotropic hormone (ACTH): massive short-term and maintenance treatment.

Authors:  C A Cape; R A Utterback
Journal:  J Neurol Neurosurg Psychiatry       Date:  1969-08       Impact factor: 10.154
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.